Literature DB >> 7629504

Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness.

J P Abastado1, Y C Lone, A Casrouge, G Boulot, P Kourilsky.   

Abstract

Major histocompatibility complex (MHC) class I molecules are cell-surface proteins that present peptides to CD8+ T cells. These peptides are mostly derived from endogenously synthesized protein. Recombinant, soluble MHC class I molecules were produced, purified, and loaded homogeneously with synthetic peptide. These MHC-peptide complexes were used to activate a T cell hybridoma. While monomers of MHC-peptide bound to the T cell, they showed no stimulatory activity. Dimers fully triggered the T cell hybridoma to secrete interleukin 2. This response was followed by a state in which the T cell was refractory to restimulation as a result of defective signal transduction through the T cell receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629504      PMCID: PMC2192121          DOI: 10.1084/jem.182.2.439

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  64 in total

1.  Mice transgenic for a gene that encodes a soluble, polymorphic class I MHC antigen.

Authors:  R Hunziker; D H Margulies
Journal:  Biotechnology       Date:  1991

2.  CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells.

Authors:  M K Jenkins; P S Taylor; S D Norton; K B Urdahl
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

Review 3.  Cross-linking and conformational change in T-cell receptors: role in activation and in repertoire selection.

Authors:  C A Janeway; U Dianzani; P Portoles; S Rath; E P Reich; J Rojo; J Yagi; D B Murphy
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1989

4.  Anti HL-A2 inhibitor in normal human serum.

Authors:  J J van Rood; A van Leeuwen; M C van Santen
Journal:  Nature       Date:  1970-04-25       Impact factor: 49.962

5.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.

Authors:  I Nicoletti; G Migliorati; M C Pagliacci; F Grignani; C Riccardi
Journal:  J Immunol Methods       Date:  1991-06-03       Impact factor: 2.303

6.  Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production.

Authors:  G R Otten; R N Germain
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

7.  Biochemical complexity of serum HLA class I molecules.

Authors:  L M Dobbe; N J Stam; J J Neefjes; M J Giphart
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

8.  The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells.

Authors:  G A Van Seventer; Y Shimizu; K J Horgan; S Shaw
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

9.  A single-chain murine class I major transplantation antigen.

Authors:  E Mottez; C Jaulin; F Godeau; J Choppin; J P Levy; P Kourilsky
Journal:  Eur J Immunol       Date:  1991-02       Impact factor: 5.532

10.  Induction of long-term but reversible unresponsiveness after activation of murine T cell hybridomas.

Authors:  F Andris; M Van Mechelen; N Legrand; P M Dubois; M Kaufman; J Urbain; O Leo
Journal:  Int Immunol       Date:  1991-06       Impact factor: 4.823

View more
  26 in total

1.  T-cell activation by soluble MHC oligomers can be described by a two-parameter binding model.

Authors:  J D Stone; J R Cochran; L J Stern
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

2.  Induction of T cell anergy by liposomes with incorporated major histocompatibility complex (MHC) II/peptide complexes.

Authors:  A J van Rensen; L S Taams; M C Grosfeld-Stulemeyer; W van Eden; D J Crommelin; M H Wauben
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

3.  Liposomes with incorporated MHC class II/peptide complexes as antigen presenting vesicles for specific T cell activation.

Authors:  A J van Rensen; M H Wauben; M C Grosfeld-Stulemeyer; W van Eden; D J Crommelin
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

4.  Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules.

Authors:  Eckart Schott; Nicolas Bertho; Qing Ge; Madelon M Maurice; Hidde L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

5.  Soluble peptide-MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC molecules.

Authors:  Qing Ge; Jennifer D Stone; M Todd Thompson; Jennifer R Cochran; Mia Rushe; Herman N Eisen; Jianzhu Chen; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

6.  Early T-cell activation biophysics.

Authors:  Nelly Henry; Claire Hivroz
Journal:  HFSP J       Date:  2009-11-10

7.  In vivo priming of IL-17(+) uveitogenic T cells is enhanced by Toll ligand receptor (TLR)2 and TLR4 agonists via γδ T cell activation.

Authors:  Aijun Zuo; Dongchun Liang; Hui Shao; Willi K Born; Henry J Kaplan; Deming Sun
Journal:  Mol Immunol       Date:  2012-02-01       Impact factor: 4.407

Review 8.  Peptide-MHC-based nanovaccines for the treatment of autoimmunity: a "one size fits all" approach?

Authors:  Xavier Clemente-Casares; Sue Tsai; Yang Yang; Pere Santamaria
Journal:  J Mol Med (Berl)       Date:  2011-04-16       Impact factor: 4.599

9.  Multivalent structure of an alphabetaT cell receptor.

Authors:  G Fernández-Miguel; B Alarcón; A Iglesias; H Bluethmann; M Alvarez-Mon; E Sanz; A de la Hera
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.